Clostridium botulinum neurotoxins - Applications in medicine and potential agents of bioterrorism

Clinical Microbiology Newsletter

Volumn 27, Issue 19, 2005, Pages 147-151

  Johnson, Eric A ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN E; RIBOSOME RNA; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN;

AUTONOMIC NERVOUS SYSTEM; BACTERIAL STRAIN; BIOLOGICAL WARFARE; BLEPHAROSPASM; BOTULISM; CEREBRAL PALSY; CLOSTRIDIUM; CLOSTRIDIUM BARATII; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM BUTYRICUM; CYTOLOGY; GENOTYPE; HEMIFACIAL SPASM; HUMAN; INFLAMMATION; MUSCLE DISEASE; NERVOUS SYSTEM; NEUROMUSCULAR DISEASE; NONHUMAN; PAIN; PARALYSIS; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; REJUVENATION; RESTRICTION MAPPING; REVIEW; SPASTICITY; STRABISMUS; TOXEMIA; WRINKLE;

EID: 25844528125     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2005.09.003     Document Type: Article

References (31)

1. Arnon, S.S. et al. 2001. Botulinum toxin as a biological weapon. Medical and public health management. JAMA 285:1059-1070.
2. Brin, M.F., M. Hallett, and J. Jankovic (ed.), 2002. Scientific and therapeutic aspects of botulinum toxin. Lippincott, Williams, and Wilkins, Philadelphia.
3. Caya, J.G. 2001. Clostridium botulinum and the opthamologist: a review of botulism, including biological warfare ramifications of botulinum toxin. Surv. Opthamol. 46:25-34.
4. Centers for Disease Control and Prevention. 1998. Botulism in the United States, 1899-1996. In Handbook for epidemiologists, clinicians, and laboratory workers. Centers for Disease Control and Prevention, Atlanta, GA.
5. Cherington, C. 1998. Clinical spectrum of botulism. Muscle Nerve 21:701-710.
6. Dineen, S.S., M. Bradshaw, and E.A. Johnson. 2003. Neurotoxin gene clusters in Clostridium botulinum type A strains: sequence comparison and evolutionary implications. Curr. Microbiol. 46:345-352.
7. Drachman, D.B. 1971. Botulinum toxin as a tool for research on the nervous system, p. 325-347. In L.L. Simpson (ed.), Neuropoisons, their pathophysiological actions, vol. 1. Poisons of animal origin, Plenum Press, New York.
8. Foran, P.G. et al. 2003. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J. Biol. Chem. 278:1363-1371.
9. Hanson, M.I. and R.C. Stevens. 2002. Structural view of botulinum neurotoxin in numerous functional states. In M.F. Brin, M.F. Hallett, and J. Jankovic (ed.), Scientific and therapeutic aspects of botulinum toxin. Lippincott, Williams and Wilkins, Philadelphia.
10. Hatheway, C.L. 1988. Botulism, p. 111-133. In A. Balows et al. (ed)., Laboratory diagnosis of infectious diseases: principles and practice. Springer-Verlag, New York.
11. Hatheway, C.L. and E.A. Johnson. 1998. Clostridium: the spore-bearing anaerobes, p. 731-782. In L. Collier, A. Balows, and M. Sussman (ed.). Topley and Wilson's microbiology and microbial infections, 9th ed., vol. 2: Systematic bacteriology. Arnold, London.
12. Humeau, Y. et al. 2000. How botulinum and tetanus neurotoxins block neurotransmitter release. Biochimie 82:427-446.
13. Jankovic, J. and M. Hallett. 1994. Therapy with botulinum toxin, 4th ed. Marcel Dekker, New York.
14. Johnson, E.A. 1999. Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins. Annu. Rev. Microbiol. 53:551-575.
15. Lacy, D.B. et al. 1998. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat. Struct. Biol. 5:898-902.
16. Lacy, D.B. and R.C. Stevens. 1999. Sequence homology and structural analysis of the clostridial neurotoxins. J. Mol. Biol. 291:1091-1104.
17. Lin, W.J. and E.A. Johnson. 1995. Genome analysis of Clostridium botulinum type A by pulsed-field gel electrophoresis. Appl. Environ. Microbiol. 61:4441-4447.
18. Montecucco, C. and G. Schiavo. 1995. Structure and function of tetanus and botulinum neurotoxins, Quart. Rev. Biophys. 28:423-472.
19. Niemann, H. 1991. Molecular biology of clostridial neurotoxins, p. 303-348. In J.E. Alouf and J.H. Freer (ed.), A sourcebook of bacterial protein toxins. Academic Press Ltd., London.
20. Oguma, K. et al. 1999. Structure and function of Clostridium botulinum progenitor toxin. J. of Tox. Tox. Rev. 18:17-34.
21. Raffestin, S. et al. 2004. Organization and regulation of the neurotoxin genes in Clostridium botulinum and Clostridium tetani. Anaerobe 10:93-100.
22. Sakaguchi, G. 1983. Clostridium botulinum toxins. Pharmacol. Ther. 19:165-194.
23. Schantz, E.J. and E.A. Johnson. 1992. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol. Rev. 56:80-92.
24. Schantz, E.J. and E.A. Johnson. 1997. Botulinum toxin: the story of its development for the treatment of human disease. Perspectives Biol. Med. 40:317-327.
25. Schiavo, G. et al. 2000. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 80:717-766.
26. Scott, A.B. 1989. Clostridial toxins as therapeutic agents, p. 399-412. In L.L. Simpson (ed.), Botulinum neurotoxin and tetanus toxin. Academic Press, San Diego.
27. Simpson, L.L. 1989. Peripheral actions of the botulinum toxins, p. 153-178. In L.L. Simpson (ed.), Botulinum neurotoxin and tetanus toxin. Academic Press, San Diego.
28. Smith, L.D.S. and H. Sugiyama. 1988. Botulism: the organism, its toxins, the disease, 2nd ed. Charles C. Thomas, Springfield, IL.
29. Sugiyama, H. 1980. Clostridium botulinum neurotoxin. Microbiol. Rev. 44:419-448.
30. Swaminathan, S. and E. Swaramoorthy. 2000. Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B. Nat. Struct. Biol. 7:693-699.
31. Turton, K., J.A. Chaddock, and K.R. Acharya. 2002. Botulinum and tetanus neurotoxins: structure, function, and therapeutic utility. Trends Biochem. Sci. 27:552-558.